Analogic (NASDAQ:ALOG) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Saturday, January 6th.
A number of other equities research analysts have also recently issued reports on ALOG. Jefferies Group restated a “hold” rating and set a $75.00 price target on shares of Analogic in a report on Wednesday, September 20th. Zacks Investment Research raised shares of Analogic from a “hold” rating to a “buy” rating and set a $93.00 price target for the company in a research report on Tuesday, October 10th.
Analogic (NASDAQ ALOG) traded down $0.95 during midday trading on Friday, hitting $84.40. The company’s stock had a trading volume of 40,000 shares, compared to its average volume of 47,244. Analogic has a 52 week low of $66.00 and a 52 week high of $89.50. The company has a market capitalization of $1,050.00, a PE ratio of -14.78, a P/E/G ratio of 4.22 and a beta of 0.86.
Analogic (NASDAQ:ALOG) last announced its earnings results on Wednesday, December 6th. The medical research company reported $0.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.32. Analogic had a negative net margin of 15.06% and a positive return on equity of 5.09%. The company had revenue of $106.90 million for the quarter, compared to the consensus estimate of $100.55 million. During the same period in the previous year, the business earned $0.43 EPS. The company’s revenue was down 11.7% on a year-over-year basis. analysts anticipate that Analogic will post 2.86 EPS for the current year.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Koch Industries Inc. boosted its stake in Analogic by 8,505.7% in the second quarter. Koch Industries Inc. now owns 321,335 shares of the medical research company’s stock valued at $317,000 after acquiring an additional 317,601 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Analogic by 18.6% during the second quarter. Dimensional Fund Advisors LP now owns 910,561 shares of the medical research company’s stock worth $66,153,000 after purchasing an additional 143,003 shares in the last quarter. Northern Trust Corp boosted its position in shares of Analogic by 53.5% during the second quarter. Northern Trust Corp now owns 372,687 shares of the medical research company’s stock worth $27,075,000 after purchasing an additional 129,855 shares in the last quarter. Citadel Advisors LLC boosted its position in shares of Analogic by 88.8% during the second quarter. Citadel Advisors LLC now owns 128,879 shares of the medical research company’s stock worth $9,363,000 after purchasing an additional 60,614 shares in the last quarter. Finally, Prudential Financial Inc. raised its holdings in shares of Analogic by 198.4% during the second quarter. Prudential Financial Inc. now owns 64,444 shares of the medical research company’s stock worth $4,682,000 after acquiring an additional 42,850 shares during the period. 97.68% of the stock is currently owned by institutional investors and hedge funds.
WARNING: “Analogic (NASDAQ:ALOG) Downgraded to “Strong Sell” at BidaskClub” was first published by TrueBlueTribune and is owned by of TrueBlueTribune. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://www.truebluetribune.com/2018/01/16/bidaskclub-lowers-analogic-alog-to-strong-sell.html.
Analogic Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.